Valganciclovir Coupons & Savings Card – Discount Prices from $71.31
Generic for: Valcyte
My prescription
Edit
450MG, Valganciclovir (30 Tablets)
Select pharmacy
CVS
$71.31
COUPON PRICE
Rite Aid
$74.99
COUPON PRICE
Walgreens
$75.90
COUPON PRICE
Albertsons
$122.68
COUPON PRICEValganciclovir savings card
Show this card to your pharmacistCVS
$71.31
BIN
ID
PCN
GRP
019876
LH35B2A2FE
CHIPPO
LHX
Powered by
Price history for Valganciclovir (generic)
30, 450MG
Average retail price for Valganciclovir
Average SaveHealth price for Valganciclovir
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
We analyzed Valganciclovir prices for (450MG, 30 Tablets) over the last 12 months. The average retail price was $250.11, while the average price using the SaveHealth discount card was $146.03. That's a savings of approximately 41.61% when using our Valganciclovir coupon.
Valganciclovir dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 450MG | 30 Tablets | $71.31 | $2.38 |
Valganciclovir Warnings
Valganciclovir is converted into ganciclovir within the body, which can have significant safety implications. It is crucial to be aware of the potential risks and necessary precautions associated with this medication. Below are key safety and warning considerations:
Blood and Bone Marrow Health: Valganciclovir can severely affect bone marrow function, resulting in reduced blood cell counts, which may lead to anemia, increased susceptibility to infections, and bleeding issues. Regular blood tests will be conducted by your healthcare provider to monitor these effects. Immediate medical attention is required if symptoms such as unusual fatigue, rapid breathing, pale skin, fast heartbeat, persistent sore throat, fever, chills, cough, easy bruising, nosebleeds, bleeding gums, or dark stools occur.
Fertility Concerns: This medication may impair fertility in both men and women, potentially causing lasting effects. Discuss family planning with your healthcare provider if you are considering having children.
Pregnancy Risks: Valganciclovir poses a risk to an unborn baby. Women should use effective contraception during treatment and for at least one month after discontinuation. Men should use condoms during treatment and for three months post-treatment to prevent harm to a partner's pregnancy.
Cancer Risks: Animal studies suggest that valganciclovir could be carcinogenic to humans. Disclose your full medical history to your healthcare provider before starting treatment.
Kidney Health: The drug may cause serious kidney damage, particularly in older adults, those who are dehydrated, or those taking other kidney-affecting medications. Ensure adequate hydration and consult your healthcare provider before introducing any new medications. Regular kidney function tests may be necessary, and dosage adjustments might be required if kidney health declines.
Contraindications: Do not use valganciclovir if you have had a severe allergic reaction to ganciclovir. Consult your healthcare provider if this applies to you.
In case of an overdose, seek emergency medical assistance immediately. Always discuss any concerns or questions with your healthcare provider to ensure safe use of valganciclovir.
Valganciclovir Side Effects
Common side effects:
- Diarrhea
- Nausea
- Headache
- Vomiting
- Upset stomach
- Dizziness
- Drowsiness
Shakiness
Less common but important to monitor:
- Difficulty sleeping
- Stomach pain
- Fever
- Low blood cell counts
Kidney problems (indicated by lab results)
Serious side effects:
- Mental or mood changes (confusion, hallucinations)
- Signs of kidney problems (changes in urine output)
- Seizures
- Nerve pain in hands and feet
- Tingling sensations
- Eye pain
- Chills
- Loss of appetite
- Back pain
- Muscle pain
- Cough
- Night sweats
- Severe allergic reaction (rash, itching, swelling of face, tongue, throat, severe dizziness, difficulty breathing)
Valganciclovir Interactions
What is the drug valganciclovir used for?
Valganciclovir is used to treat cytomegalovirus (CMV) infections, particularly in patients with weakened immune systems, such as those with HIV/AIDS or organ transplant recipients. It is also used to prevent CMV disease in high-risk organ transplant patients.
Why is valganciclovir a hazardous drug?
Valganciclovir is considered a hazardous drug because it has the potential to cause significant adverse effects, including teratogenicity (risk of causing birth defects), carcinogenicity (potential to cause cancer), and reproductive toxicity. It can also cause myelosuppression, leading to decreased blood cell counts, which can increase the risk of infections and bleeding. Due to these risks, special handling precautions are necessary to protect healthcare workers and patients.
What is the difference between acyclovir and valganciclovir?
Acyclovir and valganciclovir are both antiviral medications, but they are used to treat different types of viral infections. Acyclovir is primarily used to treat infections caused by herpes viruses, such as herpes simplex virus (HSV) and varicella-zoster virus (VZV), which causes chickenpox and shingles. Valganciclovir, on the other hand, is used to treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients, such as those who have undergone organ transplants. Additionally, valganciclovir is a prodrug of ganciclovir, meaning it is converted into ganciclovir in the body, which is the active form of the medication.
What is the black box warning on valganciclovir?
Valganciclovir carries a black box warning for hematologic toxicity, carcinogenicity, teratogenicity, and impairment of fertility. It can cause severe leukopenia, neutropenia, anemia, thrombocytopenia, and pancytopenia. It is also considered a potential carcinogen and teratogen, and it may impair fertility. Patients should be monitored closely for these risks, and the drug should be used with caution in individuals with pre-existing hematologic conditions.
Is valganciclovir a carcinogen?
Valganciclovir is not classified as a carcinogen. However, it has been shown to be mutagenic in some laboratory tests, and long-term use may carry a potential risk of cancer. It is important for patients to discuss the risks and benefits of valganciclovir with their healthcare provider.